LGALS9 and cancer: Subgroup analyses regarding cancer type clarified that increased Gal-9 expression was significantly correlated with longer OS for patients with HCC (pooled HR = 0.53, 95% CI = 0.42–0.66), along with no heterogeneity (I2 = 0.00%, P = 0.62).